Boiron Canada's CEO on Homeopathy, Integrative Health, and Proposed Supplement Changes in Canada

It's a big episode today! With information that could be a game changer when it comes to homeopathy, and the supplement industry in general.

 I'm  chatting  with Daniel Dereser, the CEO of Boiron Canada. We dive into his journey from a pharmacy student in France to CEO in the natural health industry.
Daniel talks about his early experiences with homeopathy, how it changed his perspective, and the growth of Boiron.

Then, we explore the challenges and misconceptions surrounding homeopathy, especially in Canada. We also discuss the current regulatory landscape for natural health products and the potential impact of Health Canada's cost recovery program.

It's a fascinating discussion on integrative medicine, the importance of informed choices, and how Daniel balances his high-stress role with personal wellness practices.

Homeopathics Mentioned that can be found https://www.boiron.ca/en/

Camilia
Oscillococcinum (Oscillo)
Arnica montana
Nux vomica
Calendula Cream
Aconitum Napellus

To help with the changing of Health Canada’s Regulations, click HERE to Save Our Supplements.

Natural health product regulation in Canada: Natural health product cost recovery - Canada.ca

NHPs: Save Our Supplements - CHFA


About Daniel:
President and CEO since 2015 of Boiron Canada, the Canadian subsidiary of Boiron Laboratories in France, which recently celebrated its 35th anniversary in Canada, Daniel Dereser has more than 18 years of expertise in the homeopathy industry across France, the USA, and Canada.

Graduating with a doctorate in Pharmacy (France), he also has diverse experience in strategic management, sales and marketing strategies, drug production, regulatory affairs, and government relations.

Before his official arrival at Boiron Canada, Daniel Dereser, born in Marseille, France, earned his Doctor of Pharmacy degree from the University of the Mediterranean of Aix-Marseilles in 2002. As an internal pharmacist at Solvay, Mr. Dereser began studying management at the École de Management de Lyon (EM Lyon) in 2002, focusing on industrial production management. He obtained his graduate degree from the Institute of Industrial Pharmacy in 2003.

That same year, he joined Les Laboratoires Boiron in France as a pharmacist responsible for manufacturing production. In 2004, he moved to the West Coast of the United States, where he became a pharmacist and head of the laboratory at Boiron USA, the American subsidiary of Boiron Laboratories. He also served as a specialist in professional education and as Director of Medical Development for Boiron USA.

Additionally, he lectured at the Western University of California, focusing on integrative medicine and homeopathy.

Mr. Dereser remained with Boiron USA for over 11 years until 2013. Upon his arrival at Boiron Canada, he joined the team as Director of Medical Development before becoming its current President and CEO.

Daniel Dereser sits on the Board of Directors of the Homeopathic Pharmaceutical Association of Canada (HPCA) and is also a member of the Canadian Health Food Association (CHFA). A passionate communicator, he has been involved since 2019 in the Coalition for Homeopathy in Quebec (CPHQ), which promotes and defends homeopathy in Quebec.

He actively participates in debates, forums, round tables, and media interviews to positively advance homeopathy and its role in patient well-being within integrative medicine approaches.